VEEV250117P150000
- 0.10
- 0.000.00%
Veeva Systems Newsroom
Veeva Systems Is Maintained at Overweight by Keybanc
Veeva Systems Analyst Ratings
KeyBanc Cuts Price Target on Veeva Systems to $255 From $285, Keeps Overweight Rating
KeyBanc Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $255
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $195
Piper Sandler Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $290
Wells Fargo Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $285
Stephens Initiates Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Veeva Systems Analyst Ratings
Veeva Systems Is Maintained at Underweight by Morgan Stanley
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Raises Target Price to $195
Morgan Stanley Sticks to Its Sell Rating for Veeva Systems (VEEV)
Veeva Systems Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $183
Truist Financial Keeps Their Hold Rating on Veeva Systems (VEEV)
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating, Maintains Target Price $261
Veeva Systems Analyst Ratings
Mizuho Securities Maintains Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Citi Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $307